TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) › Net IncomeTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2007: $1.91B2008: $609.00M2009: $2.00B2010: $3.33B2011: $2.76B2012: $1.96B2013: $1.27B2016: $329.00M2017: -$16.27B2018: -$2.15B2019: -$999.00M2020: -$3.99B2021: $417.00M2022: -$2.45B2023: -$559.00M2024: -$1.64B2025: $1.41B$1.41B2007Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$1.41B+186.0%2024-$1.64B-193.2%2023-$559.00M+77.1%2022-$2.45B-686.6%2021$417.00M+110.5%2020-$3.99B-299.4%2019-$999.00M+53.5%2018-$2.15B+86.8%2017-$16.27B-5043.8%2016$329.00M—2013$1.27B-35.4%2012$1.96B-28.9%2011$2.76B-17.2%2010$3.33B+66.5%2009$2.00B+228.4%2008$609.00M-68.2%2007$1.91B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share